Fcp1 phosphatase controls Greatwall kinase to promote PP2A-B55 activation and mitotic progression

Cited 20
Views 1,033
Annotations

Cite this article as: eLife 2015;4:e10399 doi: 10.7554/eLife.10399

Article
Figures and data
Jump to

Abstract

During cell division, progression through mitosis is driven by a protein phosphorylation wave. This wave namely depends on an activation-inactivation cycle of cyclin B-dependent kinase (Cdk) 1 while activities of major protein phosphatases, like PP1 and PP2A, appear directly or indirectly repressed by Cdk1. However, how Cdk1 inactivation is coordinated with reactivation of major phosphatases at mitosis exit still lacks substantial knowledge. We show here that activation of PP2A-B55, a major mitosis exit phosphatase, required the phosphatase Fcp1 downstream Cdk1 inactivation in human cells. During mitosis exit, Fcp1 bound Greatwall (Gwl), a Cdk1-stimulated kinase that phosphorylates Ensa/ARPP19 and converts these proteins into potent PP2A-B55 inhibitors during mitosis onset, and dephosphorylated it at Cdk1 phosphorylation sites. Fcp1-catalyzed dephosphorylation drastically reduced Gwl kinase activity towards Ensa/ARPP19 promoting PP2A-B55 activation. Thus, Fcp1 coordinates Cdk1 and Gwl inactivation to derepress PP2A-B55, generating a dephosphorylation switch that drives mitosis progression.

Article and author information

Author details

Rosa Della Monica

CEINGE Biotecnologie Avanzate, Naples, Italy

Competing interests
The authors declare that no competing interests exist.
Roberta Visconti

Istituto per l'endocrinologia e l'oncologia Gaetano Salvatore"", Consiglio Nazionale delle Ricerche, Naples, Italy

Competing interests
The authors declare that no competing interests exist.
Nando Cervone

CEINGE Biotecnologie Avanzate, Naples, Italy

Competing interests
The authors declare that no competing interests exist.
Angela Flavia Serpico

CEINGE Biotecnologie Avanzate, Naples, Italy

Competing interests
The authors declare that no competing interests exist.
Domenico Grieco

CEINGE Biotecnologie Avanzate, Naples, Italy

For correspondence
domenico.grieco@unina.it

Competing interests
The authors declare that no competing interests exist.

Reviewing Editor

Tony Hunter, Salk Institute, United States

Publication history

Received: July 29, 2015
Accepted: December 14, 2015
Accepted Manuscript published: December 14, 2015 (version 1)
Version of Record published: January 29, 2016 (version 2)

Copyright

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.